We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.00 | 0.41% | 1,981.00 | 1,985.00 | 1,987.00 | 1,989.00 | 1,966.00 | 1,967.00 | 427,674 | 16:35:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.88 | 4.39B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/3/2017 21:04 | Final results on Tuesday - fingers crossed. Suet | suetballs | |
06/3/2017 17:03 | Good day in a down market. | karateboy | |
03/3/2017 16:40 | Well it is not all that bad! Somebody at close has to pay 6p premium to buy 180000 shares. | karateboy | |
03/3/2017 14:31 | Yes but it's about generics which Hikma is strong in. | r ball | |
03/3/2017 14:13 | That release relates specifically to two pharmna companies, neither of which appears to be hikma? The pharma sector in general is not down. | shardview | |
03/3/2017 13:43 | See CMA release this morning for news. | r ball | |
03/3/2017 12:54 | Can anyone explain todays drop? A few bits of negative pharma news about, but nothing that seems to impact Hikma. Is it just a case of having risen too far too fast? | shardview | |
02/3/2017 19:55 | If price is right directors should be in agreement. $10b is a reasonable price. | karateboy | |
01/3/2017 21:27 | Very steady progress. I confess I took some profits to fund other ventures but am regretting it now. Still a holder but at a reduced level. Take over is possible but only I think if Directors are in agreement. Which they might be? | fez77 | |
28/2/2017 08:18 | I wonder if a take over is being quietly worked on. | karateboy | |
21/2/2017 18:57 | One step at a time. Let's break through £20.60 first then £21. | karateboy | |
21/2/2017 15:27 | Still looking positive. British Bulls:- HIKMA PHARMACEUTICALS Last Signal:STAY LONG Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 01/02/2017, 19 days ago, when the stock price was 1,848.0000. Since then HIK.L has risen by +10.06%. Financial Times As of Feb 18, 2017, the consensus forecast amongst 12 polled investment analysts covering Hikma Pharmaceuticals Plc advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Jun 30, 2016. The previous consensus forecast advised investors to purchase equity in Hikma Pharmaceuticals Plc. Broker Forecasts - January 2017 Peel Hunt 25/01 Initiates/starts Buy 2,340.00p JP Morgan Cazenove 17/01 Reiterates Overweight 2,100.00p | fez77 | |
17/2/2017 13:33 | Indeed, as happened, and now onwards............. I will be continuing to hold at present since there is still plenty of potential in my opinion. | fez77 | |
16/2/2017 08:15 | I expect £20 threshold to be broken today. | karateboy | |
13/2/2017 20:11 | No shorting here - just following the Directors faith in the company. Also The Capital Group Companies, have gone above 10% ownership threshold. These are all good signs as is the Easyhaler deal just signed with Orion. | fez77 | |
13/2/2017 10:07 | Good news and time to move up. | karateboy | |
09/2/2017 17:00 | Haha! Is that a deliberate ploy to tempt fate? Have you shorted them? G2theary made a similar comment a couple of weeks back - right before they fell to 1800! Fingers crossed! | shardview | |
09/2/2017 16:37 | Nice healthy rise today. Well on course for the 2,000 level! | fez77 | |
01/2/2017 05:42 | trump statement on big pharm was yesterday's big news. | r ball | |
31/1/2017 20:34 | West-Ward Columbus announced the addition of 95 jobs by 2020 to staff an expansion of its pharmaceutical manufacturing facility as well as a warehouse under construction in Obetz, Ohio, according to an article in Columbus Business First.The expansion is for additions to the company's line of generic drugs made at the division of Hikma Pharmaceuticals Plc. Hikma is continuing plans for growth made under former owner Boehringer Ingelheim, the story said.About 65 added technician jobs are expected by the end of 2020 to staff a 30,300-square-foot, two-story addition to the west Columbus plant. West-Ward also is building a 276,000-square-foot distribution facility in Obetz that will create another 30 jobs, according to the article. | coppertrader | |
31/1/2017 18:37 | Some large buys today:- 16:35 - 31/01 Buy 343782 1,824.00p £6,270,583.68 13:19 - 31/01 Buy 151325 1,809.00p £2,737,469.25 13:19 - 31/01 Buy 151000 1,809.00p £2,731,590.00 Keep the faith! | fez77 | |
30/1/2017 20:40 | Yes, I wonder who was selling. We'll see how it goes tomorrow. | fez77 | |
30/1/2017 16:56 | Picked up a few just before close, bit of blind optimism that the sell-off may have run its course. Then 2 massive sales go through after close! Not looking good for the morning. I still think there's value in these, but the magic 2000 seems a way off right now - to think it seemed a certainty just over a week ago. Just hope they don't edge 16/1700. | shardview | |
29/1/2017 22:17 | Agreed. Its not a share for widows and orphans! | fez77 | |
29/1/2017 14:08 | thanks for that up date interesting will hold for the next few months see how it goes but this is a roller coaster of a share. Still in the top 100 so that helps as well Most of the brokers have this as a buy as well and given the large take over a year ago should see some good news flow but can never tell with this share. My only share in this sector | mrthomas |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions